NBIX

NEUROCRINE BIOSCIENCES INC

Healthcare | Mid Cap

$0.41

EPS Forecast

$581.4

Revenue Forecast

Announcing earnings for the quarter ending 2025-03-31 soon
BLUEBluebird Bio IncDNLIDenali Therapeutics IncREPLReplimune Group IncRGENRepligen CorpTECHBio-techne CorpHALOHalozyme Therapeutics IncIOVAIovance Biotherapeutics IncCRSPCrispr Therapeutics AgNVAXNovavax IncMRNAModerna Inc